Compare PATH & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PATH | BIRK |
|---|---|---|
| Founded | 2005 | 1774 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.9B | 7.9B |
| IPO Year | 2021 | 2023 |
| Metric | PATH | BIRK |
|---|---|---|
| Price | $14.29 | $37.23 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 15 | 14 |
| Target Price | $15.50 | ★ $64.31 |
| AVG Volume (30 Days) | ★ 28.5M | 3.3M |
| Earning Date | 03-11-2026 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 83.10 |
| EPS | 0.42 | ★ 2.19 |
| Revenue | $1,553,111,000.00 | ★ $2,460,904,611.00 |
| Revenue This Year | $13.59 | $14.14 |
| Revenue Next Year | $9.54 | $14.62 |
| P/E Ratio | $34.11 | ★ $17.56 |
| Revenue Growth | 10.05 | ★ 16.22 |
| 52 Week Low | $9.38 | $38.16 |
| 52 Week High | $19.84 | $62.66 |
| Indicator | PATH | BIRK |
|---|---|---|
| Relative Strength Index (RSI) | 37.86 | 32.07 |
| Support Level | $16.17 | $42.12 |
| Resistance Level | $17.52 | $44.66 |
| Average True Range (ATR) | 0.94 | 1.83 |
| MACD | -0.34 | -0.52 |
| Stochastic Oscillator | 5.47 | 4.36 |
UiPath Inc offers an end-to-end cross-application enterprise automation platform principally with computer vision technology and user interface automations in its initial RPA offering, which remains the foundation of the platform. The platform leverages a range of automation technologies including robotic process automation, application programming interface, and artificial intelligence. UiPath's solution can automate a broad range of repetitive tasks across industries including claims processing, employee onboarding, invoice to cash, loan applications, and customer service.
Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.